Continuous Mixing of Solid Dosage Forms via Hot-Melt Extrusion - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Continuous Mixing of Solid Dosage Forms via Hot-Melt Extrusion
The author describes the benefits, processes, and practicality of using hot-melt extrusion to mix active pharmaceutical ingredients with pharmaceutical-grade polymers.


Pharmaceutical Technology
Volume 32, Issue 10, pp. 76-86


Figure 11 (All figures are courtesy of the author.)
Pelletization is a downstream process for hot-melt extrusion where the melt stream is pumped through the die, cooled and formed into a pellet, typically between 0.5 and 5 mm. In strand pelletization, "spaghetti" strands are extruded and cooled on a stainless steel or FDA-approved plastic-belt conveyer. The feedrolls of the pelletizer pull the strands and push them into the cutting assembly where cylindrical pellets are produced. Die-face pelletization is also common, where the pellets are cut at the die face and conveyed/cooled by various methods, including chilled air chimneys and vibratory towers. Because many pharmaceutical formulations tend to smear at the die face, this method should be tested prior to implementation. Smaller pellets can be used for direct capsule-filling, and in-line spheronization is also possible (see Figure 11).

For the production of flat film or sheets such as those used in transdermal or dissolvable-film applications, the process melt material is distributed in the die and cooled on rolls. The roll surface is maintained at the desired temperature by pumping a liquid (typically water or oil) through internal cooling channels. The molten material solidifies onto the roll as it cools. Take-off units are available in several different roll-stack configurations such as vertical and/or horizontal arrangements. For many flat products, the nip force across the roll face is used to "squeeze" the extrudate between the rolls. Unwind stations can be used to laminate the film onto a substrate. The final product is then either wound or cut to length.

Shape extrusion occurs when the process melt is directly extruded into a part with specific dimensions. The extrudate can be a simple rod, or complex shape, referred to as a "profile." The extruded profile is formed in the die, sized by calibration tooling, and then conveyed and supported on a conveyer with auxiliary air cooling devices. A belt puller then feeds the product to an on-demand or flywheel-type cutter. In this manner, for example, a 3 mm-diameter by 1 mm-length tablet might be produced.

Summary

Twin-screw extruders are becoming the manufacturing methodology of choice to continuously mix APIs with pharmaceutical grade polymers. Twin-screw extruders are highly flexible and efficient mixing devices suited for producing wide ranging pharmaceutical products that demand consistency and high quality. Understanding the extrusion process, as well as integration of the machine system, is necessary to ensure content uniformity for both compounds produced via hot-melt extrusion.

Charlie Martin is a general manager at Leistritz North America, tel. 908.685.2333, ext 616,




What would you do differently? Email your thoughts about this paper to
and we may post them to the site.

Additional reading

1. I. Ghebre-Sellassie and C.E. Martin, Eds., Pharmaceutical Extrusion Technology (Marcel-Dekker, New York, 2003).

2. D.B. Todd, Ed., Plastics Compounding Equipment and Processing (Hanser, New York, 1998).

3. J. Wagner and J. Vlachopolous, Eds., The SPE Guide on Extrusion Technology and Troubleshooting (Society of Plastics Engineers, Brookfield, CT, 2001).

4. S. Nowak, "Feeders in Milling and Micronization of Pharmaceutical Powders," Chem.Info (Advantage Business Media, Aug. 2006), available at www.chem.info accessed June 11, 2008.

5. M.M. Crowley et al., Eds., Drug Development and Industrial Pharmacy (Informa Healthcare, USA, 2007).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
11%
To select process for new products only
25%
To select processes for both new and legacy products
21%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here